Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: Four-year results of an open-label extension of 2 randomized clinical trials: TAP report no. 7 [4]

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)1283-1285
Number of pages3
JournalArchives of Ophthalmology
Volume123
Issue number9
DOIs
StatePublished - Sep 2005
Externally publishedYes

Fingerprint

Choroidal Neovascularization
Photosensitizing Agents
Porphyrins
Photochemotherapy
Macular Degeneration
Visual Acuity
Randomized Controlled Trials
Therapeutics
verteporfin

ASJC Scopus subject areas

  • Ophthalmology

Cite this

@article{cb77ee77192c45b18111afdff1808992,
title = "Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: Four-year results of an open-label extension of 2 randomized clinical trials: TAP report no. 7 [4]",
author = "Bressler, {Neil M}",
year = "2005",
month = "9",
doi = "10.1001/archopht.123.9.1283",
language = "English (US)",
volume = "123",
pages = "1283--1285",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
publisher = "American Medical Association",
number = "9",

}

TY - JOUR

T1 - Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration

T2 - Four-year results of an open-label extension of 2 randomized clinical trials: TAP report no. 7 [4]

AU - Bressler, Neil M

PY - 2005/9

Y1 - 2005/9

UR - http://www.scopus.com/inward/record.url?scp=24944484230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24944484230&partnerID=8YFLogxK

U2 - 10.1001/archopht.123.9.1283

DO - 10.1001/archopht.123.9.1283

M3 - Article

C2 - 16157822

AN - SCOPUS:24944484230

VL - 123

SP - 1283

EP - 1285

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

SN - 2168-6165

IS - 9

ER -